drug pipeline
Media
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio
In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...
Media
Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts
Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...
Media
GSK Makes Strategic $1.15 Billion Move to Acquire IDRx, Strengthening Its Cancer Treatment Portfolio
British pharmaceutical giant GSK has announced its agreement to acquire Boston-based biotechnology firm IDRx for up to $1.15 billion, marking a significant expansion...
Billionairesworld's billionaires
Cai Hongbin: A Pillar of Innovation in China’s Pharmaceutical Industry
Cai Hongbin has emerged as a formidable figure in China’s pharmaceutical sector, thanks to his significant contributions to Jiangsu Hengrui Medicine, one of...
